Biochemical adaptive radiation therapy based on prostate-specific antigen response in salvage radiation therapy for postoperative biochemical failure of prostate cancer. - Trial UMIN000047536
Access comprehensive clinical trial information for UMIN000047536 through Pure Global AI's free database. This phase not specified trial is sponsored by Kamagaya General Hospital and is currently Recruiting. The study focuses on Prostate cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000047536
Recruiting
other
Trial Details
University Hospital Medical Information Network • UMIN000047536
Biochemical adaptive radiation therapy based on prostate-specific antigen response in salvage radiation therapy for postoperative biochemical failure of prostate cancer.
Study Focus
Sponsor & Location
Kamagaya General Hospital
Japan
Timeline & Enrollment
N/A
May 17, 2022
N/A
ICD-10 Classifications
Malignant neoplasm of prostate
Hyperplasia of prostate
Disorder of prostate, unspecified
Other disorders of prostate
Carcinoma in situ: Prostate
Data Source
University Hospital Medical Information Network
UMIN000047536
Non-Device Trial